Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Health Lab
Researchers identify why cancer immunotherapy can cause colitis
Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment, also finding a way to deliver immunotherapy’s cancer-killing impact without the unwelcome side effect.
Health Lab
How does exposure to ‘forever chemicals’ impact your cancer risk
Pearce, professor of epidemiology at the School of Public Health and co-lead of Rogel’s cancer control and population sciences program, reflects on the project and why bringing this study to Michigan is so critical.
Health Lab
Monitoring program flags cancer patients at risk of highly toxic chemotherapy side effects
Researchers from the University of Michigan Health Rogel Cancer Center have developed a monitoring system using a research genetics program to trigger alerts about cancer patients suspected to have the DPYD gene variant.
Health Lab
Prescription drugs too costly? Changing your health plan could save money
For people with expensive prescription drugs, switching plans could save them thousands of dollars in copays. And a simple tool can help people easily compare out-of-pockets expenses for anyone with a Medicare Part D prescription plan.
News Release
U-M Health to purchase Edison platform for histotripsy, following FDA approval
Technology developed at U-M uses sound waves to destroy tissue, providing a new type of cancer therapy
News Release
New study aims to help families statewide understand their cancer risk
Historically, genetic testing for cancer risk has been underutilized, especially in underserved communities. The MiGHT Project aims to help Michigan residents at increased risk of cancer get access to clinical genetic testing.
Health Lab
Free online tool helps prostate cancer patients save on out-of-pocket drug costs
A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a Michigan Medicine study finds.
Health Lab
Study finds improved survival for incurable brain tumor, providing ‘a crack in the armor’
A potential drug candidate called ONC201 nearly doubled survival for patients with diffuse midline glioma and DIPG.
Health Lab
Changing the way immune-based cancer drugs are delivered could reduce costs by 14%
An analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.
News Release
Rogel Cancer Center awarded $37M from NCI
5-year support grant renews center’s ‘comprehensive’ status, represents 40 years of continuous funding
News Release
Rogel Cancer Center awarded $37M from NCI
The National Cancer Institute has awarded the U-M Rogel Cancer Center a grant worth $37 million over five years and renewed the center’s designation as a “comprehensive cancer center.”
News Release
U-M to partner with Singapore hospital, cancer center
Institutional partnerships will foster international collaboration around research, education, cancer care and outcomes
News Release
Program gives undergrads a ‘pathway’ to cancer careers
A 2-week summer program offers opportunity to students beyond U-M’s Ann Arbor campus
Health Lab
A ‘transformational time’ for thyroid cancer
For thyroid cancer, experts examine the current state of overdiagnosis, new therapies, health equity concerns and more.
Health Lab
Financial toxicity of cancer impacts partners’ quality of life
Financial toxicity of cancer impacts partners’ quality of life, with people reporting pain, fatigue and sleep issues tied to missed work and medical bills
